友寶在線(02429.HK)建議實行H股全流通
格隆匯5月23日丨友寶在線(02429.HK)公吿,董事會已於2024年5月23日審議和批准實行H股全流通的建議,即是將公司65,112,950股非上市內資股("內資股")轉換為公司H股。於取得所有相關批准(包括中國證監會備案)及符合所有適用法律、法規及規章後,65,112,950股內資股將被轉換為H股,而公司亦將就該等H股向聯交所申請批准該等H股在聯交所主板上市及買賣("轉換及上市")。根據公司的《公司章程》,毋須就轉換及上市於股東大會上取得公司股東批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.